ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,022.18
0.43%
Dow Jones
43,802.04
0.72%
US Dollar vs MXN
20.67276
0.82%
Brent Oil
78.675
-0.69%
Bitcoin
103,770.13
1.71%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Novartis Ag (0K9E) Cotización

Novartis Ag

Novartis Ag (0K9E)

LSE
76.79
0.00
( 0.00% )
Actualizado: 18:00:00
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
76.79
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
276
0.00 Rango del Día 0.00
76.79 Rango de 52 semanas 76.79
Capitalización de Mercado [m]
156.961B
Precio Anterior
76.79
Precio de Apertura
-
Hora
1
@
98.38
(O)
Última hora de negociación
09:36:11
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
1,114
Acciones en circulación
2,044,034,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
13.74
Beneficio por acción (BPA)
7.27
turnover
54.11B
Beneficio neto
14.85B

Acerca de Novartis Ag

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.novartis.com
Sede
Basel, Che
Fundado
-
Novartis Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0K9E. The last closing price for Novartis was US$76.79. Over the last year, Novartis shares have traded in a share price range of US$ 76.79 to US$ 76.79.

Novartis currently has 2,044,034,000 shares in issue. The market capitalisation of Novartis is US$156.96 billion. Novartis has a price to earnings ratio (PE ratio) of 13.74.

0K9E Últimas noticias

Más noticias

NOVARTIS AG CHF0.50(REGD) Novartis Delivered Strong Sales Growth, Margin Expansion And Breakthrough Innovation Launching Five...

N -- Full year net sales for continuing operations1 up 9% (cc2, +6% USD): -- Pharmaceuticals BU growing 12% (cc) driven by Cosentyx USD 3.6 billion (+28% cc), Entresto USD 1.7 billion (+71% cc...

29 Enero 2020
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis Erzielt 2019 Ein Starkes Umsatzwachstum, Margen-steigerungen Und Bahnbrechende Innovatione...

N -- Der Nettoumsatz der fortzuführenden Geschäftsbereiche1 steigt 2019 um 9% (kWk2, +6% USD): -- Die Geschäftseinheit Pharmaceuticals wächst um 12% (kWk), getragen von...

29 Enero 2020
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis A Réalisé En 2019 Une Forte Croissance De Son Chiffre D'affaires, Une Augmentation De Sa...

N -- Hausse du chiffre d'affaires net des activités poursuivies1 de 9% sur l'exercice entier (tcc2, +6% USD): -- Pharmaceuticals: cette unité opérationnelle progresse de...

29 Enero 2020
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis Completes Tender Offer For All Outstanding Shares Of The Medicines Company

N Basel, January 6, 2020 -- Novartis AG (NYSE: NVS) ("Novartis") today announced the successful completion of the previously announced tender offer by its indirect wholly-owned...

06 Enero 2020
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis Provides Update On Luster Phase Iii Studies In Patients With Uncontrolled Gina 4/5 Asthma

N -- Pooled analyses of LUSTER 1 and 2 did not support further development of Fevipiprant in asthma as a primary indication -- Fevipiprant was well tolerated with adverse events balanced across...

16 Diciembre 2019
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis Tender Offer For The Medicines Company Commences

N Basel, December 5, 2019 -- Novartis AG (NYSE: NVS) ("Novartis") today announced that its indirect wholly-owned subsidiary, Medusa Merger Corporation, a Delaware corporation...

05 Diciembre 2019
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis To Acquire The Medicines Company For Usd 9.7 Bn, Adding Inclisiran, A Potentially Transfor...

N -- Over 50 million secondary prevention patients worldwide with atherosclerotic cardiovascular disease (ASCVD) or familial hypercholesterolemia (FH) on current standard of care do not achieve...

24 Noviembre 2019
UK Regulatory

NOVARTIS AG CHF0.50(REGD) New Novartis Medicine Adakveo(R) (crizanlizumab) Approved By Fda To Reduce Frequency Of Pain Crises...

N -- Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications1 -- Adakveo reduced the annual rate of sickle cell pain crises by 45% compared to...

15 Noviembre 2019
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Shows Encouraging Results Versus Humira(R)* From First-of-its-kind Head-to-hea...

N -- Cosentyx narrowly missed statistical significance for superiority in ACR 20, the primary endpoint of the EXCEED trial, while showing numerically higher results versus Humira(R)*[1]...

01 Noviembre 2019
UK Regulatory

NOVARTIS AG CHF0.50(REGD) Novartis Announces Avxs-101 Intrathecal Study Update

N -- FDA placed a partial hold on AVXS-101 intrathecal clinical trials for SMA patients based on findings in a small pre-clinical animal study -- Adverse events that might be expected from the...

30 Octubre 2019
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10076.7976.7976.7911476.79DE
40076.7976.7976.7937376.79DE
120076.7976.7976.79111476.79DE
260076.7976.7976.79178376.79DE
520076.7976.7976.79891576.79DE
1560076.7976.7976.792122876.79DE
2600076.7976.7976.791775676.79DE

0K9E - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Novartis?
El precio actual de las acciones de Novartis es US$ 76.79
¿Cuántas acciones de Novartis están en circulación?
Novartis tiene 2,044,034,000 acciones en circulación
¿Cuál es la capitalización de mercado de Novartis?
La capitalización de mercado de Novartis es USD 156.96B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Novartis?
Novartis ha negociado en un rango de US$ 76.79 a US$ 76.79 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Novartis?
El ratio precio/beneficio de Novartis es 13.74
¿Cuál es el ratio de efectivo a ventas de Novartis?
El ratio de efectivo a ventas de Novartis es 3.77
¿Cuál es la moneda de reporte de Novartis?
Novartis presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Novartis?
El último ingresos anual de Novartis es USD 54.11B
¿Cuál es el último beneficio anual de Novartis?
El último beneficio anual de Novartis es USD 14.85B
¿Cuál es la dirección registrada de Novartis?
La dirección registrada de Novartis es PO BOX, BASEL, 4002
¿Cuál es la dirección del sitio web de Novartis?
La dirección del sitio web de Novartis es www.novartis.com
¿En qué sector industrial opera Novartis?
Novartis opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BSFABsf Enterprise Plc
3.50p
(40.00%)
13.75M
STBSecure Trust Bank Plc
458.00p
(31.61%)
762.19k
NTOGNostra Terra Oil And Gas Company Plc
0.039p
(23.81%)
460.48M
TIATialis Essential It Plc
26.50p
(23.26%)
104.56k
CBGClose Brothers Group Plc
298.40p
(21.90%)
4M
NTQEnteq Technologies Plc
1.25p
(-23.31%)
2.98M
QBTQuantum Blockchain Technologies Plc
1.525p
(-17.12%)
95.76M
QUIZQuiz Plc
0.65p
(-16.13%)
7.23M
TIRTiger Royalties And Investments Plc
0.135p
(-15.63%)
75.44M
DGIDg Innovate Plc
0.0215p
(-14.68%)
29.54M
NTVONativo Resources Plc
0.0021p
(0.00%)
2.49B
PREMPremier African Minerals Limited
0.026p
(-3.70%)
602.46M
NTOGNostra Terra Oil And Gas Company Plc
0.039p
(23.81%)
460.48M
TRPTower Resources Plc
0.0305p
(0.00%)
426.92M
SYMESupply@me Capital Plc
0.003p
(-3.23%)
424.74M

Discusión

Ver feed completo
Truenorth2016 Truenorth2016 2 minutos hace
Interesting, 52wk High is just .0013! The set up on this stock is ridiculously bullish. just 3 ticks away from 52 wk high and news has not even hit yet.
GCAN
igotthemojo igotthemojo 2 minutos hace
“He and Mary have the experience of major vehicle manufacturing and understanding of what national accounts need and their processes.”

I think their knowledge and experience is NOW telling them they will not be able to sell fcev trucks in the quantity that is needed…not even close…
NKLA
Sodapop42 Sodapop42 2 minutos hace
LMAO, I'm sure you were. I haven't hit 50 yet. What, did Henry send your 7-11 gifts cards to your house in Naples??
PHIL
FinnMcMissile FinnMcMissile 3 minutos hace
If there's no news, the stock won't go anywhere. Not sure why this surprises the naysayers. Why would the stock go up today? We have heard nothing from the company. It's very frustrating for those holding shares, but it's not doomsday. We sit and wait until we hear news, when there is news, it will
HMBL
MA52TA MA52TA 3 minutos hace
If EMA did not consider the P2b/3 trial sufficient, would it have accepted the full approval application?
AVXL
MartinLutherKing MartinLutherKing 3 minutos hace
All cancer cells killed 100% news brother🚀🚀
RNAZ
Hosai Hosai 3 minutos hace
These comments are from this recent twitter bear - https://x.com/LogarithmicDis/with_replies who a few months ago said "someone asked me to look into it" and also Jesse Brodkin. Both deploy a kind of scattergun criticism approach.
AVXL
Investor2014 Investor2014 3 minutos hace
Please see my reply to boi just now. I don't know your profession, but my post seems to apply equally well to your post.
AVXL
DayitiFromMTL DayitiFromMTL 3 minutos hace
It's GS birthday tommorow. Let's see if he'll drop a good news.
GVSI
Screech691 Screech691 3 minutos hace
Bottom bounce opportunity here for sure!
SGTM
SmoothTrader61 SmoothTrader61 3 minutos hace
Everyone selling on news?  Lol
So quiet in here
GDVM
Screech691 Screech691 4 minutos hace
Living Mulch: A Great Addition to Any Organic Garden Living Mulch by SGTM is a fantastic choice for organic gardeners. By using a living, growing layer of mulch, it enhances soil fertility, prevents erosion, and reduces the need for synthetic fertilizers. This product supports biodiversity and promo
SGTM
rodman rodman 4 minutos hace
Agreed and also I anticipate capital funding from investors and others without diluting the stock pps anymore?
UEEC
Screech691 Screech691 4 minutos hace
SGTM's Water-Less Garden: Perfect for Drought-Prone Areas For gardeners living in areas with water restrictions or frequent droughts, SGTM’s Water-Less Garden is a lifesaver. This innovative system requires minimal water while ensuring your plants receive the moisture they need. It’s an excellent op
SGTM
Whalatane Whalatane 4 minutos hace
Capt. One of the reasons I stick to taking Vascepa each day ...is your " Its the EPA stupid " posts ...so keep on doing your thing

Re the 38% RRR in a head to head with Lovaza ( or whatever EPA / DHA product they used )
How much of that was due to the harm of the DHA in the
EPD
The Danish Dude The Danish Dude 4 minutos hace
Well that is funny ex, considering how good you sometimes are at finding information.

https://iili.io/2icopxp.md.png

I can tell you right of the bat, that Advent Bioservices - thus Linda Powers - own 13.5 million NWBO shares (thus bringing the total of Linda Powers sh
NWBO
drugmanrx drugmanrx 5 minutos hace
Maybe you prefer beyond human capability philosophical thinking.

AI Overview

"Silence does not mean inactivity" means that just because someone is not speaking or outwardly expressing themselves, it does not necessarily imply they are doing nothing; they could be active
CNNA
squidink squidink 5 minutos hace
I hope you can prove your lies, orange jumpsuit!
AABB
Bionic Man Bionic Man 5 minutos hace
$931.00 pr KG. of Gallium. The price of gallium continues to climb as the need increases.  
LITM
Chartmaster Chartmaster 5 minutos hace
10's are here dog! Weee!
GCAN
Myth Myth 5 minutos hace
imo he'll be gone next year...
sloppyjones sloppyjones 5 minutos hace
For MX...
TPTW
surfkast surfkast 5 minutos hace
Scammer Steve Carnes hookng up two scams to ship water to Saudi Arabia! LOL
Greene Concepts Partners With GEMZ Corp’s BadgerBlox to Supply Fresh Water to the Middle East

MARION, NC / ACCESS Newswire / January 21, 2025 / Greene Concepts, Inc. (OTC PINK:INKW) and GEMZ Corp (OTC P
GMZP INKW
Ely Ely 5 minutos hace
Good morning dumb-dumb!! I'm glad you stayed away from drinking the ani-freeze that would have
saved you from the Greatest President in US history Donald J Trump!!

Trump signed a executive order that is good news for you, He is declaring there are only 2 genders.
So now
MartinLutherKing MartinLutherKing 5 minutos hace
It’s the new beginning brother🚀🚀🚀
RNAZ

Su Consulta Reciente

LSE
0K9E
Novartis
BIT
NSCIT2125309
African Development Bank
BIT
1WDAY
Workday
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados